Surfacide, an industry leader in UV-C low-level disinfection technology, announced today that it has been awarded a Multiple Award Schedule (MAS) contract by the U.S. General Services Administration (GSA). This contract will allow government customers and federal agencies to easily procure Surfacide's Helios® UV-C disinfection systems for their healthcare facilities. As a GSA Schedule Contractor, Surfacide has met all the requirements to sell to the federal government, making the federal purchasing process faster and more cost-effective for government agencies. Government buyers will now be able to access Surfacide products through GSA Advantage!, the government's premier online shopping superstore.
The Surfacide Helios system is the only patented, low-level UV-C disinfection solution to use a trio of light emitting 'robots' simultaneously, significantly reducing bacteria and virus on colonized surfaces. The Helios system provides UV-C energy to more exposed areas than single devices—boosting power, dosage and efficacy in a single cycle. The system can be easily moved and configured within different high-impact areas of a hospital or clinic such as patient rooms, patient bathrooms, ORs, outpatient/ambulatory surgery, burn units, labor & delivery, isolation rooms, etc.
"As a GSA Schedule Contractor, we now have the stamp of approval stating that we've met all the requirements to sell to the federal government, giving us a huge benefit in the federal purchasing process," said Gunner Lyslo, CEO & Founder of Surfacide. "We're proud to have been awarded this GSA MAS contract and are excited to provide our innovative UV-C disinfection technology to government customers more efficiently."
Surfacide is rapidly growing and has become widely adopted in the VA space. After seeing the benefits of Surfacide's scientifically-proven technology, more and more VA facilities are transitioning from single emitters to Surfacide's patented triple-emitter Helios System.
About Surfacide
Founded in 2010, Surfacide is a UV technology and infection solutions company producing scientifically proven, hospital-grade UV devices. Surfacide's award-winning Helios® System is the world's only patented, triple emitter 'robotic' UV light solution to rapidly reduce bioburden and pathogens. A trusted partner in infection prevention, Surfacide has been deployed in over 600 leading hospitals, nursing homes, dental offices, fire stations, prisons, police stations, commercial office spaces, hotels and public venues worldwide. Surfacide LLC is proud to be American-made and manufactured in Waukesha, WI.